165 related articles for article (PubMed ID: 25413697)
1. Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients.
Teixeira AA; Marrocos MS; Quinto BM; Dalboni MA; Rodrigues CJ; Carmona Sde M; Kuniyoshi M; Batista MC
Lipids Health Dis; 2014 Nov; 13():174. PubMed ID: 25413697
[TBL] [Abstract][Full Text] [Related]
2. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia).
Vučinić N; Djan I; Stokić E; Božin B; Obreht D; Stankov K; Djan M
Mol Biol Rep; 2014 Aug; 41(8):5221-7. PubMed ID: 24879316
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study.
Lai LY; Petrone AB; Pankow JS; Arnett DK; North KE; Ellison RC; Hunt SC; Rosenzweig JL; Djoussé L
Diabetes Metab Res Rev; 2015 Sep; 31(6):582-7. PubMed ID: 25656378
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: Results from a 15 year follow-up study.
Pitchika A; Markus MRP; Schipf S; Teumer A; Van der Auwera S; Nauck M; Dörr M; Felix S; Jörgen Grabe H; Völzke H; Ittermann T
Diabetes Res Clin Pract; 2022 Mar; 185():109778. PubMed ID: 35167921
[TBL] [Abstract][Full Text] [Related]
5. APOE polymorphism is associated with blood lipid and serum uric acid metabolism in hypertension or coronary heart disease in a Chinese population.
Wang C; Yan W; Wang H; Zhu J; Chen H
Pharmacogenomics; 2019 Sep; 20(14):1021-1031. PubMed ID: 31559922
[No Abstract] [Full Text] [Related]
6. Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population.
Tao MH; Liu JW; LaMonte MJ; Liu J; Wang L; He Y; Li XY; Wang LN; Ye L
Metabolism; 2011 Oct; 60(10):1488-96. PubMed ID: 21550086
[TBL] [Abstract][Full Text] [Related]
7. Association between APOE polymorphism and metabolic syndrome in Uyghur ethnic men.
Sun Y; Wei R; Yan D; Xu F; Zhang X; Zhang B; Yimiti D; Li H; Sun H; Hu C; Luo L; Yao H
BMJ Open; 2016 Jan; 6(1):e010049. PubMed ID: 26739741
[TBL] [Abstract][Full Text] [Related]
8. Effects of APOE gene ε4 allele on serum lipid profiles and risk of cardiovascular disease and tumorigenesis in southern Chinese population.
Gan C; Zhang Y; Liang F; Guo X; Zhong Z
World J Surg Oncol; 2022 Sep; 20(1):280. PubMed ID: 36057714
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
El-Lebedy D; Raslan HM; Mohammed AM
Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
[TBL] [Abstract][Full Text] [Related]
10. The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers.
Konialis C; Spengos K; Iliopoulos P; Karapanou S; Gialafos E; Hagnefelt B; Vemmos K; Zakopoulos N; Pangalos C
Adv Clin Exp Med; 2016; 25(3):471-8. PubMed ID: 27629735
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
12. Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis.
Lahrach H; Essiarab F; Timinouni M; Hatim B; El Khayat S; Er-Rachdi L; Jarir J; Kettani A; Ghalim N; Taki H; Lebrazi H; Ramdani B; Saïle R
Ren Fail; 2014 Nov; 36(10):1504-9. PubMed ID: 25155022
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
Marrocos MS; Teixeira AA; Quinto BM; Carmona Sde M; Kuniyoshi M; Rodrigues CJ; Dalboni MA; Manfredi S; Canziani ME; Batista MC
Lipids Health Dis; 2016 Jan; 15():14. PubMed ID: 26790728
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.
Lahoz C; Schaefer EJ; Cupples LA; Wilson PW; Levy D; Osgood D; Parpos S; Pedro-Botet J; Daly JA; Ordovas JM
Atherosclerosis; 2001 Feb; 154(3):529-37. PubMed ID: 11257253
[TBL] [Abstract][Full Text] [Related]
16. Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.
Deng X; Hou J; Deng Q; Zhong Z
Lipids Health Dis; 2021 Sep; 20(1):123. PubMed ID: 34587962
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E4 association with metabolic syndrome depends on body fatness.
Torres-Perez E; Ledesma M; Garcia-Sobreviela MP; Leon-Latre M; Arbones-Mainar JM
Atherosclerosis; 2016 Feb; 245():35-42. PubMed ID: 26691908
[TBL] [Abstract][Full Text] [Related]
18. Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children.
Hu P; Qin YH; Lei FY; Pei J; Hu B; Lu L
Int J Mol Sci; 2011; 12(9):5604-15. PubMed ID: 22016612
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the rs1801282 single nucleotide polymorphism of the PPARG gene in patients with metabolic syndrome.
Rocha RM; Barra GB; Rosa ÉC; Garcia ÉC; Amato AA; Azevedo MF
Arch Endocrinol Metab; 2015 Aug; 59(4):297-302. PubMed ID: 26331316
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-6 polymorphism -174G/C and metabolic syndrome in hypertensive patients.
Teixeira AA; Quinto BM; Dalboni MA; Rodrigues CJ; Batista MC
Biomed Res Int; 2015; 2015():927589. PubMed ID: 25815341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
